HeartSine Appoints Sandrine Imadec Bentata as Director of Business Development, France

BELFAST, Northern Ireland - Jan. 7, 2015 - PRLog -- HeartSine® Technologies is delighted to announce the appointment of Sandrine Imadec Bentata as the Director of Business Development, France. Bentata is an experienced sales and marketing professional with over 25 years of global business development experience in the medical and media sectors.

In her new role, Bentata will be responsible for overseeing the growth and development of business activities in France, while creating and maintaining effective relationships with HeartSine’s French distributors.

“We are excited to leverage Sandrine’s extensive sales and marketing experience to expand our market share in France,” says Volker Brand, Vice President of Sales & Marketing, Europe/ROW at HeartSine Technologies. “With a local presence in France, we can grow our distribution network, while improving support to our existing distributors.”

Bentata’s global business development and leadership expertise have contributed to major successes in company-wide sales and marketing efforts, including heavy growth in sales channels, the development of significant partnerships, and the creation of key strategic initiatives. Previously, she worked closely with multiple companies in the medical industry, including several of HeartSine’s European distributors and Ag2r-La Mondiale, a French-based insurance and supplementary retirement fund group. In these roles, Bentata provided extensive sales and marketing strategy support and helped increase sales and grow multi-channel distribution.

"I am delighted to assume this leadership role in the French market and am excited for the possibilities that lie ahead,” says Bentata. “It is so exciting to join an innovative company that has been a pioneer in portable defibrillation for over 40 years. HeartSine’s mission, values, and its positive impact on many lives are just a few factors that attracted me to the organization.”

About HeartSine Technologies

HeartSine Technologies, a world leader in personal and public access defibrillators, advances the deployment of life-saving defibrillation therapy for the treatment of Sudden Cardiac Arrest in non-traditional areas of care.

Designed for use in public areas, the company’s entire line of Automatic External Defibrillator (AED) products leverages its proprietary, clinically advanced SCOPE technology to optimize the administration of life-saving treatment.

The company’s flagship product line, the HeartSine samaritan® PAD (Public Access Defibrillator), is IP56 rated for durability and exceptional reliability to meet the unique environmental demands of public use. Its industry-leading warranty and innovative battery/electrode Pad-Pak combine to give the samaritan PAD defibrillators the lowest total cost of ownership. HeartSine is active in over 70 countries worldwide in a wide range of environments, including commercial aircraft, military and shipping facilities, manufacturing plants, offices, schools and sports clubs.

HeartSine is based in Belfast, Northern Ireland and Newtown, Pennsylvania. To learn how a HeartSine AED can save lives, please visit www.heartsine.com and follow HeartSine on Facebook and Twitter.